Literature DB >> 28535454

Frequency and severity of non-fatal opioid overdoses among clients attending the Sydney Medically Supervised Injecting Centre.

Amanda Roxburgh1, Shane Darke2, Allison M Salmon3, Timothy Dobbins2, Marianne Jauncey4.   

Abstract

BACKGROUND: Pharmaceutical opioid overdose rates have increased in recent years. The current study aimed to compare rates per 1000 injections of non-fatal overdose after heroin or oxycodone injection, and their comparative clinical severity.
METHODS: Analysis of prospectively collected data from the Sydney Medically Supervised Injecting Centre (MSIC). Severity of overdose was measured using the Glasgow Coma Scale, oxygen saturation levels, and the administration of naloxone.
RESULTS: Heroin overdoses occurred at three times the rate of oxycodone overdoses (12.7 v 4.1 per 1000 injections). Heroin overdoses appeared to be more severe than oxycodone overdoses, with higher levels of compromised consciousness (31 v 18%) and severe respiratory depression (67 v 48%), but there were no differences in naloxone doses (20 v 17%). Concurrent use of other depressants at the time of overdose was also associated with compromised consciousness, and the need for naloxone.
CONCLUSIONS: Heroin overdoses occurred at a greater rate than oxycodone overdoses, and had more severe clinical indicators.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Heroin; Overdose rates; Overdose severity; Oxycodone; Polydrug use; Prescription opioids; Supervised Injecting Centre

Mesh:

Substances:

Year:  2017        PMID: 28535454     DOI: 10.1016/j.drugalcdep.2017.02.027

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

Review 1.  Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?

Authors:  Krishnan Chakravarthy; Aneesh Goel; George M Jeha; Alan David Kaye; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2021-02-17

Review 2.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

3.  Estimating the Prevalence of Opioid use Disorder in the Cincinnati Region using Probabilistic Multiplier Methods and Model Averaging.

Authors:  Peter J Mallow; Nila Sathe; Michael Topmiller; Jennifer Chubinski; Dillon Carr; Roni Christopher
Journal:  J Health Econ Outcomes Res       Date:  2019-04-03

4.  At-a-glance - Supervised Injection Services: a community-based response to the opioid crisis in the City of Ottawa, Canada.

Authors:  Sarah DelVillano; Margaret de Groh; Howard Morrison; Minh T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2019-03       Impact factor: 3.240

5.  "Beyond Safer Injecting"-Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility.

Authors:  Vendula Belackova; Edmund Silins; Allison M Salmon; Marianne Jauncey; Carolyn A Day
Journal:  Int J Environ Res Public Health       Date:  2019-06-07       Impact factor: 3.390

6.  Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain.

Authors:  Phillip O Coffin; Christopher Rowe; Natalie Oman; Katie Sinchek; Glenn-Milo Santos; Mark Faul; Rita Bagnulo; Deeqa Mohamed; Eric Vittinghoff
Journal:  PLoS One       Date:  2020-05-04       Impact factor: 3.240

7.  The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.

Authors:  Heather Palis; Kirsten Marchand; Mohammad Karamouzian; Scott MacDonald; Scott Harrison; Daphne Guh; Kurt Lock; Suzanne Brissette; Aslam H Anis; Michael Krausz; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Addict Behav Rep       Date:  2018-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.